Skip to content

Voyager Life PLC - Result of GM & Issue of Equity


Announcement provided by

Mendell Helium plc · MDH

18/07/2024 14:15

Voyager Life PLC - Result of GM & Issue of Equity
RNS Number : 9838W
Voyager Life PLC
18 July 2024
 

 

18 July 2024

 

Voyager Life plc

 

("Voyager" or the "Company") 

 

Result of GM

Director / PDMR Shareholding

Issue of Equity

Warrants

 

Voyager is pleased to announce that at the General Meeting held earlier today, all resolutions were duly passed.

 

Issue of Equity

Following shareholder approval at the General Meeting the Company has issued 22,239,150 new ordinary shares (being the Second Tranche Shares). The Company has also issued 14,407,803 Investor Warrants and 900,000 Broker Warrants, in aggregate 15,307,803 Warrants have been issued in connection with the Fundraise.

 

Director Participation & Director / PDMR Shareholding

As part of the Fundraise, Eric Boyle, Non-Executive Chairman, and Fetlar Capital Limited (a company controlled by Nick Tulloch, Chief Executive Officer and his spouse) have subscribed, in aggregate, for £50,000 of Fundraise Shares ("Director Participation") as set out in the table below.

 

Director

Amount subscribed for in the Fundraise

Number of Fundraise Shares

Number of Investor Warrants

Resultant shareholding following Second Admission

Nick Tulloch

£25,000*

833,333

416,666

2,988,442

Eric Boyle

£25,000

833,333

416,666

2,587,474

*Participation made through Fetlar Capital Limited (a company controlled by Nick Tulloch, Chief Executive Officer and his spouse)

 

Related Party Transaction

The Director Participation (the "Transaction") is a related party transaction for the purposes of Rule 4.6 of the AQSE Growth Market Access Rulebook. Jill Overland, the director of Voyager independent of the Transaction confirms that, having exercised reasonable care, skill and diligence, the Transaction is fair and reasonable insofar as the shareholders of Voyager are concerned.

 

Admission

Application has been made for the Second Tranche Shares to be admitted to trading on the Aquis Stock Exchange AQSE Growth Market. Second Admission is expected to occur at 8:00 am on or around 19 July 2024.

 

Total voting rights

Following Second Admission, the Company's enlarged share capital will comprise 43,218,494 ordinary shares of 1 pence each. Therefore, the total number of voting rights in the Company will be 43,218,494. This figure may be used by shareholders as the denominator for calculations by which they will determine if they are required to notify their interest in the Company, or a change to their interest in the Company, under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

Unless otherwise defined, all capitalised terms used but not defined in this announcement shall have the meaning given to them in the circular published by the Company on 1 July 2024.

 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.

 

ENDS

 

Enquiries:

Voyager Life plc

 

Nick Tulloch, CEO

 

 

 

Tel: +44 (0) 1738 317 693

 

http://voyagerlife.uk

nick@voyagerlife.uk

 

Cairn Financial Advisers LLP (AQSE Corporate Adviser)

 

Ludovico Lazzaretti/Liam Murray

 

Tel: +44 (0) 20 7213 0880

SI Capital Limited (Broker)

 

Nick Emerson/Nick Briers

Tel:  +44 (0) 1483 413500

 

Stanford Capital Partners LLP (Broker)

 

Patrick Claridge/Bob Pountney

 

 

Tel:  +44 (0) 203 3650 3650/51

 

 

Brand Communications (Public & Investor Relations)

 

Alan Green

 

Tel: +44 (0) 7976 431608

 

FORWARD LOOKING STATEMENTS

This announcement includes "forward-looking statements" which include all statements other than statements of historical facts, including, without limitation, those regarding the Company's financial position, business strategy, plans and objectives of management for future operations, or any statements preceded by, followed by or that include the words "targets", "believes", "expects", "aims", "intends", "will", "may", "anticipates", "would", "could" or "similar" expressions or negatives thereof. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors beyond the Company's control that could cause the actual results, performance or achievements of the Company to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. Such forward-looking statements are based on numerous assumptions regarding the Company's present and future business strategies and the environment in which the Company will operate in the future. These forward-looking statements speak only as at the date of this announcement. The Company expressly disclaims any obligation or undertaking to disseminate any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based unless required to do so by applicable law.

 

 

1

Details of the persons discharging managerial responsibilities / person closely associated

 

a)

Name

 

Eric Boyle

2

Reason for the notification

 

a)

Position/Status

 

Non-executive Chairman

b)

Initial notification/ Amendment

 

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Voyager Life plc

b)

LEI

 

213800XIUQ3AHRZ6UF89

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial

instrument, type of

instrument

 

Identification code

 

 

 

 

Ordinary shares of 1 pence each

 

 

GB00BLD3FF28

 

b)

Nature of the transaction

Participation in the Fundraise

Investor Warrants attached to the Fundraise with an exercise price of 6 pence per share, expiring two years from Second Admission 

c)

Price(s) and volume(s)

 

 

Shares / Warrants

Price(s) (pence)

Volume(s)

Shares

3 pence

833,333

Warrants

6 pence

416,666

 

d)

Aggregated information

 

-      Aggregated volume

 

-      Price

 

 

 

 

 

e)

Date of transaction

 

18 July 2024

f)

Place of transaction

 

London Stock Exchange

 

 

1

Details of the persons discharging managerial responsibilities / person closely associated

 

a)

Name

 

Nick Tulloch (through Fetlar Capital Limited)

2

Reason for the notification

 

a)

Position/Status

 

CEO

b)

Initial notification/ Amendment

 

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Voyager Life plc

b)

LEI

 

213800XIUQ3AHRZ6UF89

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial

instrument, type of

instrument

 

Identification code

 

 

 

 

Ordinary shares of 1 pence each

 

 

GB00BLD3FF28

 

b)

Nature of the transaction

Participation in the Fundraise

Investor Warrants attached to the Fundraise with an exercise price of 6 pence per share, expiring two years from Second Admission

 

c)

Price(s) and volume(s)

 

 

Shares / Warrants

Price(s) (pence)

Volume(s)

Shares

3 pence

833,333

Warrants

6 pence

416,666

 

d)

Aggregated information

 

-      Aggregated volume

 

-      Price

 

 

 

 

 

e)

Date of transaction

 

18 July 2024

f)

Place of transaction

 

London Stock Exchange

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXMZGMNFRDGDZM]]>

View more ...

MDH announcementsAll announcements

Company

  • About
  • News
  • Investor Relations
  • Contact
  • Careers
ISO 27001 Certified

© Aquis Exchange 2024. All rights reserved.

Terms & ConditionsPrivacy PolicyModern Slavery & Human Trafficking Policy
System statusnormal